RxNorm Semantic Concepts Index - 277
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "277".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 2770 | C6 - complement component 6 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2770 | C6 - complement component 6 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2770 | C6 - complement component 6 | Designated preferred name (PT) | NO | |
| RxCUI: 2770 | C6 - complement component 6 | Full form of descriptor (FN) | NO | |
| RxCUI: 277019 | Ghrelin | Designated preferred name (PT) | NO | |
| RxCUI: 277019 | Ghrelin | Full form of descriptor (FN) | NO | |
| RxCUI: 2771 | C7 - complement component 7 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2771 | C7 - complement component 7 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2771 | C7 - complement component 7 | Designated preferred name (PT) | NO | |
| RxCUI: 2771 | C7 - complement component 7 | Full form of descriptor (FN) | NO | |
| RxCUI: 27710 | Inulase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 27710 | Inulase | Designated preferred name (PT) | NO | |
| RxCUI: 27710 | Inulase | Full form of descriptor (FN) | NO | |
| RxCUI: 27711 | Sucrose 1-fructosyltransferase | Designated preferred name (PT) | NO | |
| RxCUI: 27711 | Sucrose 1-fructosyltransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 27711 | Sucrose 1-fructosyltransferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 27712 | maize invert sugar | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 27712 | maize invert sugar | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 27712 | maize invert sugar | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2772 | C8 - complement component 8 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2772 | C8 - complement component 8 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2772 | C8 - complement component 8 | Designated preferred name (PT) | NO | |
| RxCUI: 2772 | C8 - complement component 8 | Full form of descriptor (FN) | NO | |
| RxCUI: 27721 | Iodex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 27723 | iodinated glycerol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 27723 | iodinated glycerol | Designated preferred name (PT) | NO | |
| RxCUI: 27723 | iodinated glycerol | Full form of descriptor (FN) | NO | |
| RxCUI: 27723 | iodinated glycerol | Designated preferred name (PT) | NO | |
| RxCUI: 27723 | iodinated glycerol | Full form of descriptor (FN) | NO | |
| RxCUI: 27729 | iodixanol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 27729 | iodixanol | Designated preferred name (PT) | YES | |
| RxCUI: 27729 | iodixanol | Full form of descriptor (FN) | YES | |
| RxCUI: 27729 | iodixanol | Designated preferred name (PT) | YES | |
| RxCUI: 27729 | iodixanol | Full form of descriptor (FN) | YES | |
| RxCUI: 2773 | C9 - complement component 9 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2773 | C9 - complement component 9 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2773 | C9 - complement component 9 | Designated preferred name (PT) | NO | |
| RxCUI: 2773 | C9 - complement component 9 | Full form of descriptor (FN) | NO | |
| RxCUI: 27748 | Triiodomethane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 27748 | Triiodomethane | Designated preferred name (PT) | NO | |
| RxCUI: 27748 | Triiodomethane | Full form of descriptor (FN) | NO | |
| RxCUI: 27748 | Triiodomethane | Designated preferred name (PT) | NO | |
| RxCUI: 27748 | Triiodomethane | Full form of descriptor (FN) | NO | |
| RxCUI: 27748 | Triiodomethane | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 277489 | Lunelle | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 277574 | 2,6-beta-fructan 6-levan biohydrolase | Designated preferred name (PT) | NO | |
| RxCUI: 277574 | 2,6-beta-fructan 6-levan biohydrolase | Full form of descriptor (FN) | NO | |
| RxCUI: 277597 | 2,4'-dihydroxyacetophenone dioxygenase | Designated preferred name (PT) | NO | |
| RxCUI: 277597 | 2,4'-dihydroxyacetophenone dioxygenase | Full form of descriptor (FN) | NO | |
| RxCUI: 27765 | Iothiouracil | Designated preferred name (PT) | NO | |
| RxCUI: 27765 | Iothiouracil | Full form of descriptor (FN) | NO | |
| RxCUI: 27765 | Iothiouracil | Designated preferred name (PT) | NO | |
| RxCUI: 27765 | Iothiouracil | Full form of descriptor (FN) | NO | |
| RxCUI: 27779 | iopentol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 27781 | iopromide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 27781 | iopromide | Designated preferred name (PT) | YES | |
| RxCUI: 27781 | iopromide | Full form of descriptor (FN) | YES | |
| RxCUI: 27781 | iopromide | Designated preferred name (PT) | YES | |
| RxCUI: 27781 | iopromide | Full form of descriptor (FN) | YES | |
| RxCUI: 27791 | Iotroxic acid | Designated preferred name (PT) | NO | |
| RxCUI: 27791 | Iotroxic acid | Full form of descriptor (FN) | NO | |
| RxCUI: 27791 | Iotroxic acid | Designated preferred name (PT) | NO | |
| RxCUI: 27791 | Iotroxic acid | Full form of descriptor (FN) | NO | |
| RxCUI: 27792 | ioversol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 27792 | ioversol | Designated preferred name (PT) | YES | |
| RxCUI: 27792 | ioversol | Full form of descriptor (FN) | YES | |
| RxCUI: 27792 | ioversol | Designated preferred name (PT) | YES | |
| RxCUI: 27792 | ioversol | Full form of descriptor (FN) | YES | |
| RxCUI: 27793 | ioxilan | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 27793 | ioxilan | Designated preferred name (PT) | NO | |
| RxCUI: 27793 | ioxilan | Full form of descriptor (FN) | NO | |
| RxCUI: 27793 | ioxilan | Designated preferred name (PT) | NO | |
| RxCUI: 27793 | ioxilan | Full form of descriptor (FN) | NO | |
| RxCUI: 277935 | Glucagon-like peptide 2 | Designated preferred name (PT) | NO | |
| RxCUI: 277935 | Glucagon-like peptide 2 | Full form of descriptor (FN) | NO |